Health Trials

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

ConditionCoronavirus Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversità Vita-Salute San Raffaele

About this trial

Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions

Eligibility criteria

Qualifiers

Patients admitted to hospital with biological samples positive for SARS-CoV-2

Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease

Patients discharged from emergency department with biological samples positive for SARS-CoV-2

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Observational Study

Treatment groups

6,000 Participants
are divided into 1 treatment group

Locations

13
AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute20132, MilanLombardy, Italy
Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute2012, MilanLombardy, Italy
Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -20132, MilanLombardy, Italy
Department of Internal Medicine - IRCCS San Raffaele Scientific Institute20132, MilanLombardy, Italy

Sponsors and collaborators

Università Vita-Salute San Raffaele

Lead sponsor

Source ClinicalTrials.gov